---
figid: PMC9253705__gr7
figtitle: Pexmetinib suppresses osteoclast formation and breast cancer induced osteolysis
  via P38/STAT3 signal pathway
organisms:
- NA
pmcid: PMC9253705
filename: gr7.jpg
figlink: /pmc/articles/PMC9253705/figure/f0035/
number: F7
caption: Pexmetinib suppresses osteoclast formation and breast cancer metastasis via
  P38/STAT3 signal pathway. A graph abstract showing the working model of the role
  of Pexmetinib in inhibiting osteoclastogenesis and breast cancer metastasis.
papertitle: Pexmetinib suppresses osteoclast formation and breast cancer induced osteolysis
  via P38/STAT3 signal pathway.
reftext: Zhiwei Jie, et al. J Bone Oncol. 2022 Aug;35:100439.
year: '2022'
doi: 10.1016/j.jbo.2022.100439
journal_title: Journal of Bone Oncology
journal_nlm_ta: J Bone Oncol
publisher_name: Elsevier
keywords: P38 mitogen-activated protein kinase | Pexmetinib | Osteoclast | Breast
  cancer | Osteolysis
automl_pathway: 0.9558942
figid_alias: PMC9253705__F7
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC9253705__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9253705__gr7.html
  '@type': Dataset
  description: Pexmetinib suppresses osteoclast formation and breast cancer metastasis
    via P38/STAT3 signal pathway. A graph abstract showing the working model of the
    role of Pexmetinib in inhibiting osteoclastogenesis and breast cancer metastasis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NFATC1
  - TRAP
  - ACP5
  - CD40LG
  - TRAF2
  - TRRAP
  - TDRD7
  - SCYL1
  - CTSK
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - STAT3
  - SMR3B
  - MMP2
---
